Advertisement

Pneumonia and Empyema

  • Imad Y. Haddad
  • David N. Cornfield
Chapter

Keywords

Respiratory Syncytial Virus Hematopoietic Stem Cell Transplantation Pediatric Intensive Care Unit Aspiration Pneumonia Primary Ciliary Dyskinesia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kaisho T, Akira S. Pleiotropic function of toll-like receptors. Microbes Infect 2004;6:1388–1394.PubMedCrossRefGoogle Scholar
  2. 2.
    Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB. Myeloid differentiation factor 88 is essential for pulmonary host defense againstPseudomonas aeruginosa but notStaphylococcus aureus. J Immunol 2004;172:3377–3381.PubMedGoogle Scholar
  3. 3.
    Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 2005;560:11–18.PubMedCrossRefGoogle Scholar
  4. 4.
    Schonwetter BS, Stolzenberg ED, Zasloff MA. Epithelial antibiotics induced at sites of inflammation. Science 1995;267:1645–1648.PubMedCrossRefGoogle Scholar
  5. 5.
    Skerrett SJ, Liggitt HD, Hajjar AM, Ernst RK, Miller SI, Wilson CB. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol 2004;287:L143–L152.PubMedCrossRefGoogle Scholar
  6. 6.
    Wright JR. Host defense functions of pulmonary surfactant. Biol Neonate 2004;85:326–332.PubMedCrossRefGoogle Scholar
  7. 7.
    Yang S, Milla C, Panoskaltsis-Mortari A, Ingbar DH, Blazar BR, Haddad IY. Human surfactant protein a suppresses T cell–dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice. Am J Respir Cell Mol Biol 2001;24:527–536.PubMedGoogle Scholar
  8. 8.
    Schaeffer LM, McCormack FX, Wu H, Weiss AA. Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infect Immun 2004;72:7124–7130.PubMedCrossRefGoogle Scholar
  9. 9.
    Mehrad B, Strieter RM, Standiford TJ. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. J Immunol 1999;162:1633–1640.PubMedGoogle Scholar
  10. 10.
    Strieter RM, Belperio JA, Keane MP. Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis 2003;16:193–198.PubMedGoogle Scholar
  11. 11.
    McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002;346:429–437.PubMedCrossRefGoogle Scholar
  12. 12.
    Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, Marrie TJ, Sarosi GA, Torres A, Yu VL. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993;148:1418–1426.PubMedGoogle Scholar
  13. 13.
    Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243–250.PubMedCrossRefGoogle Scholar
  14. 14.
    Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE, Jr. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004;350:443–450.PubMedCrossRefGoogle Scholar
  15. 15.
    Hon KL, Leung CW, Cheng WT, Chan PK, Chu WC, Kwan YW, Li AM, Fong NC, Ng PC, Chiu MC, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 2003;361:1701–1703.PubMedCrossRefGoogle Scholar
  16. 16.
    Hsieh YC, Hsueh PR, Lu CY, Lee PI, Lee CY, Huang LM. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused byStreptococcus pneumoniae in children in Taiwan. Clin Infect Dis 2004;38:830–835.PubMedCrossRefGoogle Scholar
  17. 17.
    Wang RS, Wang SY, Hsieh KS, Chiou YH, Huang IF, Cheng MF, Chiou CC. Necrotizing pneumonitis caused byMycoplasma pneumoniae in pediatric patients: report of five cases and review of literature. Pediatr Infect Dis J 2004;23:564–567.PubMedCrossRefGoogle Scholar
  18. 18.
    Hacimustafaoglu M, Celebi S, Sarimehmet H, Gurpinar A, Ercan I. Necrotizing pneumonia in children. Acta Paediatr 2004;93:1172–1177.PubMedCrossRefGoogle Scholar
  19. 19.
    Korppi M, Kiekara O, Heiskanen-Kosma T, Soimakallio S. Comparison of radiological findings and microbial aetiology of childhood pneumonia. Acta Paediatr 1993;82:360–363.PubMedCrossRefGoogle Scholar
  20. 20.
    Bettenay FA, de Campo JF, McCrossin DB. Differentiating bacterial from viral pneumonias in children. Pediatr Radiol 1988;18:453–454.PubMedCrossRefGoogle Scholar
  21. 21.
    Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, Kallinen S, Sten M, Tarkiainen A, Ronnberg PR, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J 1998;17:986–991.PubMedCrossRefGoogle Scholar
  22. 22.
    Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Douglas RG, Bennet JF, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone; 1990:540–544.Google Scholar
  23. 23.
    Murray PR, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975;50:339–344.PubMedGoogle Scholar
  24. 24.
    Uphoff CC, Brauer S, Grunicke D, Gignac SM, MacLeod RA, Quentmeier H, Steube K, Tummler M, Voges M, Wagner B, et al. Sensitivity and specificity of five different mycoplasma detection assays. Leukemia 1992;6:335–341.PubMedGoogle Scholar
  25. 25.
    Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998;338:1741–1751.PubMedCrossRefGoogle Scholar
  26. 26.
    Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004;170:22–48.PubMedCrossRefGoogle Scholar
  27. 27.
    Jantunen E, Piilonen A, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T, Ruutu P. Diagnostic aspects of invasiveAspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000;25:867–871.PubMedCrossRefGoogle Scholar
  28. 28.
    Maertens J, Glasmacher A, Selleslag D, Ngai A, Ryan D, Layton M, Taylor A, Sable C, Kartsonis N. Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study. Clin Infect Dis 2005;41:e9–e14.PubMedCrossRefGoogle Scholar
  29. 29.
    Hayes-Jordan A, Benaim E, Richardson S, Joglar J, Srivastava DK, Bowman L, Shochat SJ. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg 2002;37:446–452.PubMedCrossRefGoogle Scholar
  30. 30.
    Gulbahce HE, Pambuccian SE, Jessurun J, Woodard P, Steiner ME, Manivel JC, Hite S, Ramsay NK, Baker KS. Pulmonary nodular lesions in bone marrow transplant recipients: impact of histologic diagnosis on patient management and prognosis. Am J Clin Pathol 2004;121:205–210.PubMedCrossRefGoogle Scholar
  31. 31.
    Gordon SM, LaRosa SP, Kalmadi S, Arroliga AC, Avery RK, Truesdell-LaRosa L, Longworth DL. Should prophylaxis forPneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999;28:240–246.PubMedCrossRefGoogle Scholar
  32. 32.
    Pescovitz MD, Brook B, Jindal RM, Leapman SB, Milgrom ML, Filo RS. Oral ganciclovir in pediatric transplant recipients: a pharmacokinetic study. Clin Transplant 1997;11:613–617.PubMedGoogle Scholar
  33. 33.
    Tolep K, Getch CL, Criner GJ. Swallowing dysfunction in patients receiving prolonged mechanical ventilation. Chest 1996;109:167–172.PubMedCrossRefGoogle Scholar
  34. 34.
    Knight PR, Rutter T, Tait AR, Coleman E, Johnson K. Pathogenesis of gastric particulate lung injury: a comparison and interaction with acidic pneumonitis. Anesth Analg 1993;77:754–760.PubMedCrossRefGoogle Scholar
  35. 35.
    DePaso WJ. Aspiration pneumonia. Clin Chest Med 1991;12:269–284.PubMedGoogle Scholar
  36. 36.
    Corwin RW, Irwin RS. The lipid-laden alveolar macrophage as a marker of aspiration in parenchymal lung disease. Am Rev Respir Dis 1985;132:576–581.PubMedGoogle Scholar
  37. 37.
    Wolfe JE, Bone RC, Ruth WE. Effects of corticosteroids in the treatment of patients with gastric aspiration. Am J Med 1977;63:719–722.PubMedCrossRefGoogle Scholar
  38. 38.
    Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care–associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53:1–36.PubMedGoogle Scholar
  39. 39.
    Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999;103:e39.PubMedCrossRefGoogle Scholar
  40. 40.
    Garrett DO, McKibben P, Levine G, Jarvis WR. Prevalence of nosocomial infections in pediatric intensive care unit patients at US Children’s Hospitals [abstr]. Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections March 5–9, 2000.Google Scholar
  41. 41.
    Fabregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, de la Bellacasa JP, Bauer T, Cabello H. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999;54:867–873.PubMedCrossRefGoogle Scholar
  42. 42.
    Andrews CP, Coalson JJ, Smith JD, Johanson WG Jr. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest 1981;80:254–258.PubMedCrossRefGoogle Scholar
  43. 43.
    Meduri GU, Wunderink RG, Leeper KV, Beals DH. Management of bacterial pneumonia in ventilated patients. Protected bronchoalveolar lavage as a diagnostic tool. Chest 1992;101:500–508.PubMedCrossRefGoogle Scholar
  44. 44.
    Meduri GU. Diagnosis and differential diagnosis of ventilator-associated pneumonia. Clin Chest Med 1995;16:61–93.PubMedGoogle Scholar
  45. 45.
    Marquette CH, Georges H, Wallet F, Ramon P, Saulnier F, Neviere R, Mathieu D, Rime A, Tonnel AB. Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis 1993;148:138–144.PubMedGoogle Scholar
  46. 46.
    Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999;340:627–634.PubMedCrossRefGoogle Scholar
  47. 47.
    Bryant RE, Salmon CJ. Pleural empyema. Clin Infect Dis 1996;22:747–762.PubMedCrossRefGoogle Scholar
  48. 48.
    Antony VB, Mohammed KA. Pathophysiology of pleural space infections. Semin Respir Infect 1999;14:9–17.PubMedGoogle Scholar
  49. 49.
    Light RW, MacGregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77:507–513.PubMedGoogle Scholar
  50. 50.
    Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest 1997;111:970–980.PubMedCrossRefGoogle Scholar
  51. 51.
    Brook I. Microbiology of empyema in children and adolescents. Pediatrics 1990;85:722–726.PubMedGoogle Scholar
  52. 52.
    Chen CF, Soong WJ, Lee YS, Jeng MJ, Lin MY, Hwang B. Thoracic empyema in children: early surgical intervention hastens recovery. Acta Paediatr Taiwan 2003;44:93–97.PubMedGoogle Scholar
  53. 53.
    Light RW. Pleural diseases. Dis Mon 1992;38:261–331.PubMedGoogle Scholar
  54. 54.
    Barnes NP, Hull J, Thomson AH. Medical management of parapneumonic pleural disease. Pediatr Pulmonol 2005;39:127–134.PubMedCrossRefGoogle Scholar
  55. 55.
    Ray TL, Berkenbosch JW, Russo P, Tobias JD. Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients. J Intensive Care Med 2004;19:44–50.PubMedCrossRefGoogle Scholar
  56. 56.
    Ozcelik C, Ulku R, Onat S, Ozcelik Z, Inci I, Satici O. Management of postpneumonic empyemas in children. Eur J Cardiothorac Surg 2004;25:1072–1078.PubMedCrossRefGoogle Scholar
  57. 57.
    Meier AH, Smith B, Raghavan A, Moss RL, Harrison M, Skarsgard E. Rational treatment of empyema in children. Arch Surg 2000;135:907–912.PubMedCrossRefGoogle Scholar
  58. 58.
    Chen CY, Chen JS, Huang LM, Lee PI, Lu CY, Lee YC, Lu FL. Favorable outcome of parapneumonic empyema in children managed by primary video-assisted thoracoscopic debridement. J Formos Med Assoc 2003;102:845–850.PubMedGoogle Scholar
  59. 59.
    Schultz KD, Fan LL, Pinsky J, Ochoa L, Smith EO, Kaplan SL, Brandt ML. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 2004;113:1735–1740.PubMedCrossRefGoogle Scholar
  60. 60.
    McLaughlin FJ, Goldmann DA, Rosenbaum DM, Harris GB, Schuster SR, Strieder DJ. Empyema in children: clinical course and long-term follow-up. Pediatrics 1984;73:587–593.PubMedGoogle Scholar
  61. 61.
    Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262–268.PubMedCrossRefGoogle Scholar
  62. 62.
    Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della PR, Giorgio C, Blasi F, Umberger R, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005;171:242–248.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2009

Authors and Affiliations

  • Imad Y. Haddad
    • 1
  • David N. Cornfield
    • 2
  1. 1.Department of PediatricsBanner Medical CenterPhoenixUSA
  2. 2.Divisions of Pediatric Pulmonology and Critical Care Medicine Lucille Packard Children’s HospitalStanford University School of MedicinePalo AltoUSA

Personalised recommendations